H.B. Fuller launches new biocompatible adhesive

H.B. Fuller Launches New Biocompatible Adhesive H.B. Fuller, one of the world's leading adhesive suppliers, announced the launch of Swift®melt 1515-I, its first biocompatible product developed for the IMEA region. The product is designed for use in skin-adhesive microporous medical tape applications in the unique climate conditions of the Indian subcontinent, characterized by high temperatures and humidity. Swift®melt 1515-I delivers effective high adhesion with high-temperature and shear resistance, ensuring safe and rapid bonding. The product provides effective performance, balanced adhesion and ease of removal, and has been rigorously tested for cytotoxicity and approved by ISO 10993-5. The adhesive shows no toxic properties for human cells and can be effectively used in medical applications in hospitals and home care settings. Manish Dwivedi, Flexible Materials Manager at H.B. Fuller India, stated: "H.B. Fuller's R&D team in India developed this new technology in our laboratory in Pune in response to IMEA market characteristics to support advanced skin-adhesive products suitable for medical use, such as nonwoven surgical applications. Our products have been used in medical applications worldwide for over twenty years, providing diverse solutions for this important industry and accelerating innovation." Population pressure, the prevalence of medical diseases and surgical procedures, as well as chronic and traumatic wounds, are making the global medical tapes and bandages market a significantly growing market. According to the "Medical Tapes and Bandages Market – Global Forecast to 2026" report prepared by MarketsandMarkets™, this market is expected to reach USD 8.59 billion globally by 2026. Source